Alume Biosciences Gains FDA Breakthrough Therapy Designation for Bevonescein
SAN DIEGO, Calif. — September 25, 2026 Alume Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
SAN DIEGO, Calif. — September 25, 2026 Alume Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
London, United Kingdom, September 22, 2026 Smith+Nephew has announced U.S. FDA 510(k) clearance for its LANDMARK™ Total Knee System...
VAUGHAN, Ontario — September 11, 2026 Bausch + Lomb Corporation announced that its next-generation SeeLyra™ femtosecond laser has received...
Audubon, Pennsylvania, USA, September 3, 2026 Globus Medical has announced that its Excelsius3D™ Imaging System has received the CE...
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
New Brunswick, New Jersey, August 18, 2026 Johnson & Johnson has published a new Future of Digital Surgery report...
Tel Aviv, Israel, August 19, 2026 Galmed Pharmaceuticals announced successful first-in-human proof-of-concept results for a novel intraoperative tissue assessment...
Fruita, Colorado, August 12, 2026 Neuralytix, LLC announced the full commercial availability of its iD3 System, an FDA 510(k)-cleared...
VANCOUVER, BC, July 30, 2026 Total Flow Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
MONTEREY, Calif., July 29, 2026 Elevation Spine has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Saber-C®...
